#Thinksabio latest news
$ATOS Atossa Therapeutics Highlights Progress in RECASTâ„¢ DCIS Platform Trial at Early Detection Research Conference; Laura Esserman, MD, MBA, to Discuss Active-Surveillance Strategy and Novel Endocrine Agents
$ATOS Atossa Therapeutics Highlights Progress in RECASTâ„¢ DCIS Platform Trial at Early Detection Research Conference; Laura Esserman, MD, MBA, to Discuss Active-Surveillance Strategy and Novel Endocrine Agents